The article ‘Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines’ by Flanagan et al. appeared in the October 2020 edition of Frontiers in Immunology. The authors review current knowledge about the immune response to SARS-CoV-2 as it pertains to the design of effective and safe SARS-CoV-2 vaccines and the range of novel and established approaches to vaccine development being taken. They provide details of some of the frontrunner vaccines and discuss potential issues including adverse effects, scale-up and delivery.
- Mix-and-match COVID vaccines trigger potent immune response May 24, 2021
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca in Denmark and Norway May 12, 2021
- The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety April 17, 2021
- The UK Expert Haematology Panel (EHP) has produced guidance on the syndrome of Thrombosis and Thrombocytopenia occurring after coronavirus vaccination April 8, 2021
- Why is it so hard to investigate the rare side effects of COVID vaccines? April 7, 2021